Lipocalin 2 is present in the EAE brain and is modulated by natalizumab

Multiple sclerosis (MS) is a demyelinating disease that causes major neurological disability in young adults. A definitive diagnosis at the time of the first episode is still lacking, but since early treatment leads to better prognosis, the search for early biomarkers is needed. Here we characterize...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques, Fernanda, Mesquita, Sandro D., Sousa, João C., Coppola, Giovanni, Gao, Fuying, Geschwind, Daniel H., Columba-Cabezas, Sandra, Aloisi, Francesca, Degn, Matilda, Cerqueira, João J., Sousa, Nuno, Correia-Neves, Margarida, Palha, Joana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414908/
https://www.ncbi.nlm.nih.gov/pubmed/22907989
http://dx.doi.org/10.3389/fncel.2012.00033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414908/
https://www.ncbi.nlm.nih.gov/pubmed/22907989
http://dx.doi.org/10.3389/fncel.2012.00033

Ejemplares similares